KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： Stina M,Singel

第一单位： Division of Hematology-Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Cell Biology University of Texas Southwestern Medical Center, Dallas, TX, USA.

作者： Stina M,Singel ^[1] ; Crystal,Cornelius ^[2] ; Elma,Zaganjor ^[3] ; Kimberly,Batten ^[2] ; Venetia R,Sarode ^[4] ; Dennis L,Buckley ^[5] ; Yan,Peng ^[4] ; George B,John ^[6] ; Hsiao C,Li ^[7] ; Navid,Sadeghi ^[7] ; Woodring E,Wright ^[2] ; Lawrence,Lum ^[2] ; Timothy W,Corson ^[8] ; Jerry W,Shay ^[9]

作者单位： Division of Hematology-Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Cell Biology University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[1] Department of Cell Biology University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[2] Cell Biology, Harvard Medical School, Boston, MA, USA. ^[3] Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[4] Department of Chemistry, Yale University, New Haven, CT, USA. ^[5] Clinical Laboratory Services, University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[6] Division of Hematology-Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[7] Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA. ^[8] Department of Cell Biology University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Jerry.Shay@utsouthwestern.edu. ^[9]